A detailed history of State Street Corp transactions in Organon & Co. stock. As of the latest transaction made, State Street Corp holds 9,295,345 shares of OGN stock, worth $192 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
9,295,345
Previous 9,442,763 1.56%
Holding current value
$192 Million
Previous $136 Million 28.34%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$13.78 - $18.8 $2.03 Million - $2.77 Million
-147,418 Reduced 1.56%
9,295,345 $175 Million
Q4 2023

Feb 14, 2024

SELL
$10.95 - $17.32 $46.9 Million - $74.1 Million
-4,280,830 Reduced 31.19%
9,442,763 $136 Million
Q3 2023

Nov 14, 2023

BUY
$16.59 - $23.77 $11.3 Million - $16.1 Million
678,839 Added 5.2%
13,723,593 $238 Million
Q2 2023

Aug 14, 2023

BUY
$19.27 - $24.63 $4.14 Million - $5.29 Million
214,766 Added 1.67%
13,044,754 $271 Million
Q1 2023

May 15, 2023

SELL
$21.42 - $32.08 $667,233 - $999,292
-31,150 Reduced 0.24%
12,829,988 $302 Million
Q4 2022

Feb 14, 2023

BUY
$23.31 - $28.61 $2.03 Million - $2.49 Million
87,199 Added 0.68%
12,861,138 $359 Million
Q3 2022

Nov 15, 2022

SELL
$23.4 - $34.25 $4.26 Million - $6.24 Million
-182,054 Reduced 1.41%
12,773,939 $299 Million
Q2 2022

Aug 15, 2022

BUY
$31.66 - $38.9 $31.6 Million - $38.8 Million
997,608 Added 8.34%
12,955,993 $437 Million
Q1 2022

May 16, 2022

BUY
$30.45 - $39.36 $79.2 Million - $102 Million
2,599,728 Added 27.78%
11,958,385 $418 Million
Q4 2021

Feb 14, 2022

BUY
$28.67 - $37.13 $9.77 Million - $12.7 Million
340,838 Added 3.78%
9,358,657 $285 Million
Q3 2021

Nov 15, 2021

BUY
$28.63 - $35.64 $15.2 Million - $19 Million
532,584 Added 6.28%
9,017,819 $296 Million
Q2 2021

Aug 16, 2021

BUY
$28.45 - $38.0 $241 Million - $322 Million
8,485,235 New
8,485,235 $257 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $5.26B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.